Invitris logo
StartupHealth & bio

Invitris

Creating new protein-based drugs at scale

Visit invitris.comSee on the map
About

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

BiotechNanotechnologyDrug discovery
Facts
Website
invitris.com
City
Munich
Country
Germany
YC batch
Winter 2023
Team
6 people
Stage
Early stage
AI-native
No

See it on the Munich mapSource Spot something wrong?

More Health & bio in Munich

Is this your company?

Claim this profile

Free and instant: prove you run invitris.com and edit the profile yourself.

  • Your logo, office address and founder photos
  • The ✓ Verified mark next to Invitris across the site
  • Open roles listed on the Hiring board
  • A followed link back to your website
For your website

A rank card with Invitris's standing on Labspie, or a simple badge. Both link to this profile and update themselves.

Invitris is listed on Labspie